Listen to RFI News
Expand Player
 
Listen Download Podcast
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 09/20 13h00 GMT
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 09/19 13h00 GMT
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 09/18 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/05 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/04 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/03 13h00 GMT
To take full advantage of multimedia content, you must have the Flash plugin installed in your browser. To connect, you need to enable cookies in your browser settings. For an optimal navigation, the RFI site is compatible with the following browsers: Internet Explorer 8 and above, Firefox 10 and +, Safari 3+, Chrome 17 and + etc.
Asia-Pacific

Chinese whistleblower says France's Sanofi bribed doctors to up sales

media An employee enters pharmaceutical company Sanofi in Shanghai. Reuters/Aly Song

French pharmaceutical company Sanofi says it is taking seriously the claims that its staff bribed more than 500 Chinese doctors with thousands of euros, six years ago. A whistleblower has told a Chinese newspaper that Sanofi staff paid off the doctors in an attempt to increase sales.

 

The whistleblower, who would not reveal his identity other than using the pseudonym “Piegun” or “bacon” in Chinese, provided four documents to China’s 21st Century Business Herald newspaper. The report shows that Sanofi paid a total of 1.71 million yuan, or 280,000 euros, to doctors in 79 hospitals in 2007.

Most of the payments were made to hospitals in Beijing, Shanghai, the southern city of Guangzhou and Hangzhou in the east. The payments were categorised as “research expenses,” according to the report.

Sanofi allegedly paid doctors 90 yuan, or 13 euros, every time patients bought one of its products. The largest payout was reportedly 11,200 yuan.

Sanofi has responded by saying it has a zero tolerance policy when it comes to unethical practice. A company statement said: “Sanofi has established processes in place for reviewing and addressing such issues in a manner that is consistent with our legal and ethical obligations.

The company has not announced whether or not it is investigating the allegations but said they were taking them "very seriously."

Last week, a Sanofi office in China was visited by officials, but the company said it did not know the purpose of the inquiry.

The allegations against the French company come after four executives from British drugs giant GlaxoSmithKline were arrested for alleged bribery last month.

A top Chinese economic planner is currently investigating 60 foreign and domestic pharmaceutical companies over their prices.

 

Related
 
Sorry but the period of time connection to the operation is exceeded.